Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs listed are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.

Advice for healthcare professionals:

If any of the listed products are supplied and/or dispensed, please ensure that patients are aware of the missing information as highlighted. It is important that any patients who notice the listed symptoms should seek immediate medical advice.

As a general reminder, patients who experience side effects from taking any medicines should be encouraged to report a suspected problem or incident via the Yellow Card scheme (www.mhra.gov.uk/yellowcard) and seek medical advice accordingly.

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.